| 000 | 01897 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250516063822.0 | ||
| 264 | 0 | _c20120731 | |
| 008 | 201207s 0 0 eng d | ||
| 022 | _a1879-355X | ||
| 024 | 7 |
_a10.1016/j.ijrobp.2011.07.005 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aQuon, Harvey | |
| 245 | 0 | 0 |
_aQuality of life after hypofractionated concomitant intensity-modulated radiotherapy boost for high-risk prostate cancer. _h[electronic resource] |
| 260 |
_bInternational journal of radiation oncology, biology, physics _cJun 2012 |
||
| 300 |
_a617-23 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAndrogen Antagonists _xtherapeutic use |
| 650 | 0 | 4 | _aDose Fractionation, Radiation |
| 650 | 0 | 4 |
_aFemur Head _xdiagnostic imaging |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aNeoplasm Staging |
| 650 | 0 | 4 |
_aOrgans at Risk _xdiagnostic imaging |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 |
_aProstate-Specific Antigen _xblood |
| 650 | 0 | 4 |
_aProstatic Neoplasms _xblood |
| 650 | 0 | 4 | _aQuality of Life |
| 650 | 0 | 4 | _aRadiography |
| 650 | 0 | 4 |
_aRadiotherapy, Intensity-Modulated _xmethods |
| 650 | 0 | 4 |
_aRectum _xdiagnostic imaging |
| 650 | 0 | 4 | _aRisk |
| 650 | 0 | 4 |
_aUrinary Bladder _xdiagnostic imaging |
| 700 | 1 | _aCheung, Patrick C F | |
| 700 | 1 | _aLoblaw, D Andrew | |
| 700 | 1 | _aMorton, Gerard | |
| 700 | 1 | _aPang, Geordi | |
| 700 | 1 | _aSzumacher, Ewa | |
| 700 | 1 | _aDanjoux, Cyril | |
| 700 | 1 | _aChoo, Richard | |
| 700 | 1 | _aKiss, Alex | |
| 700 | 1 | _aMamedov, Alexandre | |
| 700 | 1 | _aDeabreu, Andrea | |
| 773 | 0 |
_tInternational journal of radiation oncology, biology, physics _gvol. 83 _gno. 2 _gp. 617-23 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ijrobp.2011.07.005 _zAvailable from publisher's website |
| 999 |
_c21308142 _d21308142 |
||